Results 1 to 10 of about 1,875 (183)

Review on melanosis coli and anthraquinone-containing traditional Chinese herbs that cause melanosis coli [PDF]

open access: yesFrontiers in Pharmacology, 2023
Backgrounds: The incidence of melanosis coli (MC) has gradually increased annually, attracting significant attention and efforts into this field. A potential risk for MC is the long-term use of anthraquinone laxatives in patients with constipation.
Zhang R   +7 more
exaly   +4 more sources

Melanosis Coli: A Helpful Contrast Effect or a Harmful Pigmentation? [PDF]

open access: yesClinical Medicine Insights Gastroenterology, 2018
Background: Melanosis coli, a brown discoloration of colonic mucosa, is considered as a benign condition mainly observed in patients under chronic anthranoid laxatives. Recent data link this condition with an increased adenoma detection rate.
Abu Baker, Fadi, Amir Mari, Dan Feldman
exaly   +3 more sources

Colonoscopic Resolution of Melanosis Coli After Cessation of Senna Laxative Use [PDF]

open access: yesInternational Medical Case Reports Journal
Toshimi Chiba,1,* Ting Wang,1,* Satoshi Kikuchi2,* 1Division of Internal Medicine, Department of Oral Medicine, Iwate Medical University, Morioka, Iwate, Japan; 2Department of Gastroenterology, Sanai Hospital, Morioka, Iwate, Japan*These ...
Toshimi Chiba
exaly   +4 more sources

Case Report: A case of melanosis coli complicated by pneumatosis intestinalis–induced volvulus [PDF]

open access: yesFrontiers in Medicine
Melanosis coli (MC) combined with pneumatosis intestinalis (PI) is an exceedingly rare condition. We present the case of an 85-year-old male with a history of chronic constipation, hypertensive heart disease, and type 2 diabetes mellitus. The patient was
Bai S, Wang J, Song T, Sun W.
exaly   +4 more sources

Increased Colonic Fluorodeoxyglucose Uptake in Melanosis Coli-A Case Series of Three Patients. [PDF]

open access: yesGastro Hep Adv, 2022
We report 3 Japanese cases with increased colonic 18-fluorodeoxyglucose (FDG) uptake in association with melanosis coli. Case 1: A 56-year-old woman received 18-FDG positron emission tomography (PET) for comprehensive medical checkup.
Katsumata R   +11 more
europepmc   +2 more sources

Case report: Melanosis coli combined with colon cancer, causality or coincidence? [PDF]

open access: yesFront Surg, 2022
The habitual use of laxative containing anthraquinone glycosides is considered to be the main cause of melanosis coli (MC). In the past, most scholars considered MC to be a benign and reversible disease.
Zhao W, Chen J, Xing H, Yu J, Liu Q.
europepmc   +2 more sources

Melanosis coli in patients with colon cancer. [PDF]

open access: yesPrz Gastroenterol, 2017
Intoduction: Melanosis coli is a benign lesion affecting the mucosa of the large intestine. There is a relationship between the presence of melanosis and anthraquinone laxative use.
Biernacka-Wawrzonek D   +6 more
europepmc   +2 more sources

Melanosis coli: Harmless pigmentation? A case-control retrospective study of 657 cases. [PDF]

open access: yesPLoS One, 2017
The association of melanosis coli with the development of colorectal polyps remains uncertain.From a total of 18263 patients who had received colonoscopy in our hospital, 219 with melanosis coli cases and 438 controls matched by age and sex (at 1:2 ratio)
Liu ZH   +5 more
europepmc   +2 more sources

Melanosis coli in a peritoneal dialysis patient: a case report. [PDF]

open access: yesJ Med Case Rep, 2021
Background Patients who undergo peritoneal dialysis (PD) are at risk of gut bacteria translocation leading to peritonitis when there is chronic diarrhea.
Zakaria NF   +4 more
europepmc   +2 more sources

Chronic California herbal tea use causing biopsy-proven Melanosis coli. [PDF]

open access: yesSAGE Open Med Case Rep
Melanosis coli is a dark to brown pigmentation of the colon due to lipofuscin deposition within the cytoplasm of cells. It is a benign condition associated with excessive use of laxatives, particularly those that are anthracene derivatives and common ...
Bizuneh S, Fentahun S, Lema G, Azaje A.
europepmc   +2 more sources

Home - About - Disclaimer - Privacy